SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059349
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:05
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506627_10q.htm 10-Q 535225
2 EXHIBIT 31.1 tv506627_ex31-1.htm EX-31.1 9519
3 EXHIBIT 31.2 tv506627_ex31-2.htm EX-31.2 9729
4 EXHIBIT 32.1 tv506627_ex32-1.htm EX-32.1 4981
5 EXHIBIT 32.2 tv506627_ex32-2.htm EX-32.2 4968
  Complete submission text file 0001144204-18-059349.txt   7446603

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20180930.xml EX-101.INS 2316078
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20180930.xsd EX-101.SCH 43989
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20180930_cal.xml EX-101.CAL 35159
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20180930_def.xml EX-101.DEF 345395
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20180930_lab.xml EX-101.LAB 340070
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20180930_pre.xml EX-101.PRE 380897
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 181177943
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1